A poor planning culture is holding back business growth in the UK and damaging its economy, according to a new report from ...

Former Domainex CEO Tom Mander and two colleagues have bought a 30-year-old life sciences company - Pharmagene Discovery ...

UKRI Research England has today published an independent report by Tony Hickson, Chief Business Officer at Cancer Research UK ...

Wellcome, which has substantial interests in Cambridge, has awarded £5.3 million to Wysa to fund a scale-up study that will adapt a clinically validated digital mental health intervention for ...

AstraZeneca, which has just launched on the New York Stock Exchange in addition to its London and Stockholm listings, is ...

Marshall Aerospace and Nordiq Products have begun an industrial cooperation project to support the development and path to ...

Law firm Howes Percival has confirmed its Milton Keynes office will move to The Pinnacle on Midsummer Boulevard in April from ...

Three of the four winners in the latest Trinity Bradfield Prize in Cambridge were CleanTech plays and the fourth has eco ...

Reflections of this month’s JP Morgan Week when many of the Life Sciences world of companies, investors and commentators ...

Cambridge headquartered life science giant AstraZeneca has made a sensational bow on Wall Street, opening at $187.50 a share and soon sailing past $191.22p for an intra-day market cap of $591.712 ...

A $5.3 billion deal that sent interest soaring in the AI global cyber security sector just 15 months ago when Thoma Bravo in ...

The life sciences outlook for 2026 is being shaped by three interlocking forces, writes Paul Hughes, Managing Director, Life ...